Related Experiment Videos
Endoluminal radiotherapy for rectal tumors
G Tanum1, J Wiig, O K Andersen
1Department of Oncology, Norwegian Radium Hospital, Oslo, Norway.
Oncology
|October 21, 1998
Summary
Endoluminal radiotherapy effectively controls rectal tumors in elderly patients unfit for surgery. This treatment showed minimal side effects, offering a viable option for malignant and premalignant rectal conditions.
Area of Science:
- Oncology
- Radiotherapy
Background:
- Rectal tumors, including adenocarcinoma and adenomas, pose treatment challenges, especially in elderly patients with poor medical conditions.
- Radical surgery or colostomy may not be feasible for all patients with rectal tumors due to age or comorbidities.
Purpose of the Study:
- To evaluate the efficacy and safety of endoluminal radiotherapy for local tumor control in patients with rectal tumors.
- To assess side effects associated with endoluminal radiotherapy in this patient population.
Main Methods:
- A cohort of 12 patients with adenocarcinoma and 10 with villous/adenovillous adenomas received endoluminal radiotherapy with curative intent.
- Treatment was administered between 1989 and 1995, focusing on patients unable to undergo conventional surgery.
Main Results:
- Local tumor control was achieved, with a small number of patients requiring secondary treatment (surgery or iridium implant) for residual tumor.
- Two patients with adenomas experienced local relapse after initial treatment.
- No serious adverse side effects were reported during the study period.
Conclusions:
- Endoluminal radiotherapy is an effective treatment for achieving local tumor control in patients with malignant or premalignant rectal tumors.
- This modality is particularly suitable for elderly patients in poor medical condition who are not candidates for radical surgery or colostomy.
- The treatment demonstrates a favorable safety profile with minimal serious side effects.